Search research articles
Contact Us
Filters
Showing results (21-30 of 389) with videos related to
Page
of 39
Sort By:
The Urologic Clinics of North America
|
April 18, 2015
Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practice
John P Sfakianos, Matthew D Galsky
Current Treatment Options in Oncology
|
December 12, 2023
Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions
Eric J Miller, Matthew D Galsky
The Mount Sinai Journal of Medicine, New York
|
November 25, 2010
Bladder cancer: current management and opportunities for a personalized approach
Matthew D Galsky, Simon J Hall
Nature Clinical Practice. Urology
|
February 14, 2007
High-dose bicalutamide after radiotherapy for locally advanced prostate cancer: a standard of care?
Matthew D Galsky, William Kevin Kelly
Expert Review of Anticancer Therapy
|
June 9, 2007
Outcomes and prognosis in advanced renal cell carcinoma
Matthew D Galsky, Nicholas J Vogelzang
Cancer
|
June 27, 2014
Mind the gap: efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics
Matthew D Galsky, William K Oh
Current Opinion in Urology
|
August 13, 2016
Combining chemotherapy and immune checkpoint blockade
Ana Collazo-Lorduy, Matthew D Galsky
European Urology
|
April 23, 2019
Atezolizumab in "Real World" Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?
Vaibhav G Patel, Matthew D Galsky
European Urology Focus
|
July 9, 2025
The Evolving Treatment Paradigm for Upper Tract Urothelial Carcinoma
Saad O Atiq, Matthew D Galsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Current approaches to the management of bladder cancer in older patients
Kristian D Stensland, Matthew D Galsky
Page
of 39
Search research articles
Search
Showing results (21-30 of 389) with videos related to
Sort By:
Page
of 39
The Urologic Clinics of North America
|
April 18, 2015
Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practice
John P Sfakianos, Matthew D Galsky
Current Treatment Options in Oncology
|
December 12, 2023
Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions
Eric J Miller, Matthew D Galsky
The Mount Sinai Journal of Medicine, New York
|
November 25, 2010
Bladder cancer: current management and opportunities for a personalized approach
Matthew D Galsky, Simon J Hall
Nature Clinical Practice. Urology
|
February 14, 2007
High-dose bicalutamide after radiotherapy for locally advanced prostate cancer: a standard of care?
Matthew D Galsky, William Kevin Kelly
Expert Review of Anticancer Therapy
|
June 9, 2007
Outcomes and prognosis in advanced renal cell carcinoma
Matthew D Galsky, Nicholas J Vogelzang
Cancer
|
June 27, 2014
Mind the gap: efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics
Matthew D Galsky, William K Oh
Current Opinion in Urology
|
August 13, 2016
Combining chemotherapy and immune checkpoint blockade
Ana Collazo-Lorduy, Matthew D Galsky
European Urology
|
April 23, 2019
Atezolizumab in "Real World" Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?
Vaibhav G Patel, Matthew D Galsky
European Urology Focus
|
July 9, 2025
The Evolving Treatment Paradigm for Upper Tract Urothelial Carcinoma
Saad O Atiq, Matthew D Galsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Current approaches to the management of bladder cancer in older patients
Kristian D Stensland, Matthew D Galsky
Page
of 39